- Staat
- IN
- Alter
- 14,0
- Geschlecht
- M
- Eingang
- 31.03.2022
- Impfdatum
- 29.03.2022
- Beginn
- 29.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Loss of consciousness
Symptomtext
Patient passed out in the Lobby approximately 10 minutes after being vaccinated, the patients mother stated earlier during the visit that the patient has never passed out during or after vaccinations when asked by the Medical Assistant.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 22.11.2021
- Impfdatum
- 22.11.2021
- Beginn
- 22.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Crying
Dizziness
Dyskinesia
Fall
Head injury
Seizure
Symptomtext
patient receiving age appropriate shots. TdaP and Menveo given then Gardasil. Within 1 minute of last injection, she began to feel faint and fell forward and was caught by the M A but hit her head on the tile. She then began to seize with arms jerking for a few seconds (less than 20) she was placed on the ground and on her side. She then came to and started to cry and answered questions appropriately. Her pulse was 86. Her pulse ox was 100 percent. Her BP was 100/65. EMS was called. She was taken to ED for further evaluation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE, MILD SEASONAL ALLERGIES
- Andere Medikamente
- ZYRTEC AND MULTIVITAMIN
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 05.11.2021
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Hair colour changes
Presyncope
Symptomtext
presyncopal episode, assisted to ambulate to patient room, transferred to examination table in supine position, was found to be euglcyemic, normocardic, improved s/p 20minutes, given food and cup of water, reported physician's hair looked purple, which resolved following as above
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- headaches
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- nkda
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 01.11.2021
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood glucose normal
Fall
Syncope
Symptomtext
This nurse gave pt shots when she turned to throw needles away in sharps container. Pt fainted and fell off examine table to the ground. Pt was rushed to by this nurse, Dr. , and pt mom. Pt was given a cool cloth for forehead, ice pack for head, vs taken, and blood sugar taken. All vs within normal ranges. Pt given time to rest and monitored by physician.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- none
- Allergien
- no
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 22.07.2022
- Impfdatum
- 22.07.2022
- Beginn
- 22.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Back pain
Dizziness
Electrocardiogram normal
Hyperhidrosis
Immediate post-injection reaction
Nausea
Pyrexia
Vomiting
Symptomtext
lightheadedness, dizziness immediately after vaccination; patient lay on exam table for 30 minutes after vaccination. once assessed as clinically stable, sent home. within 2 hours of receiving vaccine, developed nausea, intractable vomiting, weakness, diaphoresis. was returned to clinic where vital signs and initial assessment and evaluation/treatment performed., increase in fever 100.4 F to tmax 101.3F, lower back pain. Brother received same vaccines without any incident.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Back pain
- Hospital-Tage
- -
- Labordaten
- 7/22/2022 EKG - within normal limits
- Aktuelle Erkrankungen
- febrile 100.4F
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- iodine, pollen extract, shellfish derived products
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 15,0
- Geschlecht
- F
- Eingang
- 07.07.2022
- Impfdatum
- 11.04.2022
- Beginn
- 11.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Rash
Rash pruritic
Symptomtext
COVID 19 Pfizer dose given beyond use date. Pt developed itchy bumps over her arms one week after receiving vaccine. Pt was given Benadryl. Bumps resolved after one week. Pt recovered and is back to baseline
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- Pfizer COVID 19 2nd dose on 10/18/21. Developed itchy bumps over arms one week after receiving vaccine. Resolved after one week.
- Staat
- NY
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 10.05.2022
- Impfdatum
- 16.02.2022
- Beginn
- 16.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Rash
Symptomtext
Pt developed generalized rash the night after she received HPV #3 and Men B #1.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- -
- Andere Medikamente
- Fluoxetine
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 41,0
- Geschlecht
- U
- Eingang
- 23.05.2023
- Impfdatum
- 17.05.2023
- Beginn
- 17.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE; expired dose of GARDASIL-9; This spontaneous report was received from a pharmacist referring to a 41-year-old patient of unknown gender. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported. On 17-MAY-2023, the patient was vaccinated with HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) injection (0.5 ml/ once, lot#: U007652, expiration date: 14-APR-2023; route of administration, and anatomical location were not reported) for prophylaxis (expired product administered). No additional adverse event (AE) was reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- -
- Geschlecht
- U
- Eingang
- 28.04.2023
- Impfdatum
- 25.04.2023
- Beginn
- 25.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additonal AE; An HCP is reporting an AE on behalf of a patient. The HCP reports that the patient was adminstered an expired dose of GARDASIL 9. No additional clarifying statements or AE details were provided and no additional AE's were reported. No PQC.; This spontaneous report was received from medical assistant, concerning to patient of unknown gender and age. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 25-APR-2023, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 0.5 milliliter intramuscularly (lot #U007652, has been verified to be a valid lot, expiration date: 14-APR-2023) for prophylaxis (strength was not provided). No additional adverse event were reported (expired product administered) (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 11.10.2022
- Impfdatum
- 01.10.2022
- Beginn
- 01.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Swelling
Symptomtext
Redness/swelling
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 08.07.2022
- Impfdatum
- 11.04.2022
- Beginn
- 11.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Symptomtext
COVID 19 Pfizer dose given beyond use date. There were no signs or symptoms of side effects. There was no treatment necessary.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 23.06.2022
- Impfdatum
- 23.03.2022
- Beginn
- 23.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Pfizer vaccine given beyond use date
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 15,0
- Geschlecht
- F
- Eingang
- 27.05.2022
- Impfdatum
- 05.04.2022
- Beginn
- 19.05.2022
- Tage bis Beginn
- 44,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
Pfizer COVID-19 vaccine administered to patient after the beyond use date. No adverse event reported by patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Diabetes Type 1, Hypothyroid, Microalbuminemia
- Vorgeschichte
- Diabetes Type 1, Hypothyroid, Microalbuminemia
- Andere Medikamente
- Humalog KwikPen, Levothyroxine, Insulin Glargine
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 29.04.2022
- Impfdatum
- 01.02.2022
- Beginn
- 01.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 21.03.2022
- Impfdatum
- 11.01.2022
- Beginn
- 11.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
Pediatric Pfizer Vaccine Lot Number FK5127, was improperly stored in an Immunizations Freezer that maintained a temperature between -15 Celsius and -24 Celsius. Per the Manufacture?s guidelines the vaccine must be stored in a Refrigerator maintaining temperature of 2-8 Degrees Celsius or an Ultra-Low Cold Freezer maintaining temperature of -90C or lower. The patient received the vaccine that was improperly stored. Treatment: Not required, patient did not report any adverse reactions to the Vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 09.02.2022
- Impfdatum
- 08.02.2022
- Beginn
- 08.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Wrong product administered
Symptomtext
Meningococcal B was given instead of Meningococcal Conjug. No adverse reaction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.02.2022
- Impfdatum
- 01.12.2014
- Beginn
- 15.12.2020
- Tage bis Beginn
- 2.206,0
- Dosis
- 4
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Inappropriate schedule of product administration
No adverse event
Symptomtext
No additional AEs reported; patient received 4 doses of GARDASIL or GARDASIL 9; 1st dose was administered on 12/2014, 2nd dose 12/15/2020, 3rd dose 2/26/2021; This spontaneous report was received from a physician and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not provided. In December 2014, the patient was vaccinated with the first dose of either hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided) or quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided) (unidentified Merck hpv vaccine administered (name and lot number not provided)). Then, on 15-DEC-2020, the patient received the second dose with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (inappropriate schedule of product administration). On 26-FEB-2021, the third dose with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was given. On 22-JAN-2022, a fourth dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was administered (extra dose administered) (0.5 ml, by intramuscular route, Lot #U007652, expiration date on 14-APR-2023). No additional Adverse Experiences (AEs) were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- -
- Geschlecht
- U
- Eingang
- 09.12.2021
- Impfdatum
- 03.11.2021
- Beginn
- 03.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; Administered GARDASIL 9 following a non-supported temperature excursion; This spontaneous report was received from a registered nurse regarding a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant therapies, drug reactions and allergies were not provided. On 03-NOV-2021, the patient was vaccinated with a non-supported temperature excursion (improperly stored dose) (product storage error) of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) 0.5 milliliter, lot number U007652, and expiration date 14-APR-2023 (route of administration was not provided) for prophylaxis. There was no additional adverse event reported. Administered doses of vaccine experienced the temperature excursion of -0.45 degrees Celsius (?C) for 1 hour. There was previous excursions reported of 0 ?C for 3 hours. This is one of several reports received from the same reporter. ; Sender's Comments: US-009507513-2111USA002695:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.12.2021
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No adverse effect reported; temperature excursion / temperature 34.8 F; This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. There was no information regarding their medical history, concurrent conditions nor concomitant therapies provided. On 26-OCT-2021, the patient was vaccinated with an improperly stored dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) lot # U007652, expiration date 14-APR-2023 (exact dose, route of administration and anatomical location were not provided) for prophylaxis (product storage error). The administered vaccine was stored in a temperature of 34.8 degree Fahrenheit (F) for 192 hours. No previous temperature excursion occurred. No adverse effect was reported. This is one of several reports from the same reporter. ; Sender's Comments: US-009507513-2112USA000788: US-009507513-2112USA000785: US-009507513-2112USA000790: US-009507513-2112USA000791: US-009507513-2112USA000789:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.12.2021
- Impfdatum
- 19.10.2021
- Beginn
- 19.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No adverse effect reported; temperature excursion / temperature 34.8 F; This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. There was no information regarding their medical history, concurrent conditions nor concomitant therapies provided. On 19-OCT-2021, the patient was vaccinated with an improperly stored dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) lot # U007652, expiration date 14-APR-2023 (exact dose, route of administration and anatomical location were not provided) for prophylaxis (product storage error). The administered vaccine was stored in a temperature of 34.8 degree Fahrenheit (F) for 192 hours. No previous temperature excursion occurred. No adverse effect was reported. This is one of several reports from the same reporter. ; Sender's Comments: US-009507513-2112USA000788: US-009507513-2112USA000785: US-009507513-2112USA000790: US-009507513-2112USA000789: US-009507513-2112USA000792:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 24.11.2021
- Impfdatum
- 19.11.2021
- Beginn
- 19.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
None, patient rescheduled for correct vaccination
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- GERD, Chronic Vaginitis, Anxiety/Depression, Oligomenorrhea, vitamin D deficiency, Cervical high risk HPV, HSV-1
- Andere Medikamente
- multivitamins, Zyrtec, fluocinolone
- Allergien
- Nitrofurantoin, Sulfa
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 02.11.2021
- Impfdatum
- 02.11.2021
- Beginn
- 02.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 4
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Patient received an extra dose of HPV that was not needed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 01.11.2021
- Impfdatum
- 01.11.2021
- Beginn
- 01.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Patient was only eleven years old and received Pfizer vaccine approved for ages 12 and older.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 01.11.2021
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
HPV vaccine given , client wanted Flu vaccine. Client outside range for HPV vaccine. Client had no adverse reaction to HPV vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- n/a
- Allergien
- nka
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 26.10.2021
- Impfdatum
- 26.10.2021
- Beginn
- 26.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- HPV vaccine given 2 months after first dose on 8/4/2021 which will now require a third dose. Parent was informed of early dose that was administered by physician. Parent at this time has no questions or concerns.
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 18.10.2021
- Impfdatum
- 08.10.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
No adverse event
Symptomtext
A dose of GARDASIL 9 was administered to a patient that is 8 weeks and 5 days pregnant; No additional AE reported; This spontaneous prospective pregnancy report was received from a medical assistant, regarding a 34-year-old female patient. The patient's drug reactions or allergies included sulfa allergies; her concomitant medications included doxylamine succinate (+) pyridoxine hydrochloride (BONJESTA) and prenatal vitamins. It was not reported information regarding the patient's medical history or her concurrent conditions. The patient became pregnant with last menstrual period (LMP) calculated as 08-AUG-2021 (and estimated date of delivery (EDD) of 15-MAY-2022), based on a pregnancy gestation reported as 8 weeks and 5 days, at the time of the report. On 08-OCT-2021, the patient was vaccinated with a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 0.5 milliliters (mL) administered intramuscularly (lot number U007652 has been verified to be a valid lot number, expiration date reported and established as 14-APR-2023) (vaccination scheme frequency, anatomical location of administration were not reported) as routine vaccination (prophylaxis) (exposure during pregnancy). At the time of the report, the pregnancy outcome was pending, the fetal outcome was not provided, and the patient did not experience any additional adverse events (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Sulfonamide allergy
- Andere Medikamente
- BONJESTA; PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 02.10.2021
- Impfdatum
- 26.09.2021
- Beginn
- 26.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Symptomtext
no adverse events
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 02.10.2021
- Impfdatum
- 29.09.2021
- Beginn
- 29.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Symptomtext
No adverse effects.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- No.
- Aktuelle Erkrankungen
- N/a
- Vorgeschichte
- N/a
- Andere Medikamente
- N/a
- Allergien
- Nka
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 02.10.2021
- Impfdatum
- 30.09.2021
- Beginn
- 30.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- N/a.
- Aktuelle Erkrankungen
- N/a
- Vorgeschichte
- N/a
- Andere Medikamente
- N/a
- Allergien
- Nka
- Vorherige Impfungen
- -